Rosetta Genomic

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Rosetta Genomic ( ROSG) develops and commercializes diagnostic tests based on microRNAs. This stock is trading up 10.7% at $7.60 in recent trading.

Today's Range: $6.82-$7.89

52-Week Range: $1.40-$36.45

Volume: 1.3 million

Three-Month Average Volume: 276,887

>>22 Biopharma Stocks With Breakout Potential

From a technical perspective, ROSG has been on fire lately, skyrocketing from $1.40 to today's high of $7.89 a share on massive volume. That move has now pushed ROSG right below its 200-day moving average of $8.26.

Traders should continue to look for long-biased trades if ROSG can manage to take outs its 200-day with high-volume. Look for a sustained move or close over $8.26 with volume that's near or above 276,887 shares. At last check, ROSG has hit $7.89 at the high of the day on volume that's well above its three-month average action. If we get that move soon, look for ROSG to challenge its March high of $9.60 and possibly take it out.

If you liked this article you might like

Doubt Is OK; The Lay of the Land: Doug Kass' Views

Here Is One of My Best Stock Ideas, Doug Kass Explains

Ulta Beauty, Radian Group, AllianceBerstein Holdings: 'Mad Money' Lightning Round

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

All the Rallying Big Bank Stocks Look Very Risky, Doug Kass Says